Emerging technologies are paving the way for the future of probiotics and prebiotics, offering exciting opportunities for innovation and improvement. Through the lens of emerging technologies and future directions, advances in genomic sequencing and bioinformatics enable the identification of new probiotic strains with enhanced therapeutic properties. Additionally, cutting-edge techniques like CRISPR and gene editing are being used to create more resilient and effective probiotics tailored to specific health conditions. The rise of personalized nutrition is another key development, with technologies that analyze an individual’s microbiome to recommend tailored probiotic and prebiotic interventions. Furthermore, innovations in delivery systems, such as nanoencapsulation, ensure that probiotics reach their target site in the gut with maximum efficacy. These technologies are not only enhancing the effectiveness of probiotics and prebiotics but also providing new avenues for research and applications in health and disease prevention.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India